{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T13:54:34Z","timestamp":1772891674358,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3-4","license":[{"start":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T00:00:00Z","timestamp":1476576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T00:00:00Z","timestamp":1476576000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["26450450"],"award-info":[{"award-number":["26450450"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Azabu University Research Services Division","award":["Young Scientist Research Training Award"],"award-info":[{"award-number":["Young Scientist Research Training Award"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s11259-016-9664-7","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T22:36:05Z","timestamp":1476570965000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Expression of HIF-1\u03b1 ODD domain fused canine caspase 3 by EGFR promoter-driven adenovirus vector induces cytotoxicity in canine breast tumor cells under hypoxia"],"prefix":"10.1007","volume":"40","author":[{"given":"Mariko","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Asamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takefumi","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyo","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Mizuguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,16]]},"reference":[{"key":"9664_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1136\/vr.159.22.733","volume":"159","author":"JG Bergman","year":"2006","unstructured":"Bergman JG, Muniz M, Sutton D, Fensome R, Ling F, Paul G (2006) Comparative trial of the canine parvovirus, canine distemper virus and canine adenovirus type 2 fractions of two commercially available modified live vaccines. Vet Rec 159:733\u2013736","journal-title":"Vet Rec"},{"key":"9664_CR2","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/030098588302000201","volume":"20","author":"SR Gilbertson","year":"1983","unstructured":"Gilbertson SR, Kurzman ID, Zachrau RE, Hurvitz AI, Black MM (1983) Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Vet Pathol 20:127\u2013142","journal-title":"Vet Pathol"},{"key":"9664_CR3","first-page":"2013","volume":"62","author":"H Harada","year":"2002","unstructured":"Harada H, Hiraoka M, Kizaka-Kondoh S (2002) Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells. Cancer Res 62:2013\u20132018","journal-title":"Cancer Res"},{"key":"9664_CR4","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.prevetmed.2015.03.018","volume":"120","author":"M Inoue","year":"2015","unstructured":"Inoue M, Hasegawa A, Hosoi Y, Sugiura K (2015) A current life table and causes of death for insured dogs in Japan. Preventive Veterinary Medicine 120:210\u2013218","journal-title":"Preventive Veterinary Medicine"},{"key":"9664_CR5","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1128\/MCB.24.13.5757-5766.2004","volume":"24","author":"M Kaluzova","year":"2004","unstructured":"Kaluzova M, Kaluz S, Lerman MI, Stanbridge EJ (2004) DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX. Mol Cell Biol 24:5757\u20135766","journal-title":"Mol Cell Biol"},{"key":"9664_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7883\/yoken1952.47.157","volume":"47","author":"Y Kanegae","year":"1994","unstructured":"Kanegae Y, Makimura M, Saito I (1994) A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol 47:157\u2013166","journal-title":"Jpn J Med Sci Biol"},{"key":"9664_CR7","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1124\/mol.106.027029","volume":"70","author":"Q Ke","year":"2006","unstructured":"Ke Q, Costa M (2006) Hypoxia-inducible factor-1 (HIF-1). Mol Pharmacol 70:1469\u20131480","journal-title":"Mol Pharmacol"},{"key":"9664_CR8","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.7605428","volume":"266","author":"NW Kim","year":"1994","unstructured":"Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011\u20132015","journal-title":"Science"},{"key":"9664_CR9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jcpa.2012.08.009","volume":"148","author":"NH Kim","year":"2013","unstructured":"Kim NH, Lim HY, Im KS, Kim JH, Sur JH (2013) Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers. J Comp Pathol 148:298\u2013306","journal-title":"J Comp Pathol"},{"key":"9664_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0304-4165(01)00194-5","volume":"1568","author":"N Koizumi","year":"2001","unstructured":"Koizumi N, Mizuguchi H, Hosono T, Ishii-Watabe A, Uchida E, Utoguchi N, Watanabe Y, Hayakawa T (2001) Efficient gene transfer by fiber-mutant adenoviral vectors containing RGD peptide. Biochim Biophys Acta 1568:13\u201320","journal-title":"Biochim Biophys Acta"},{"key":"9664_CR11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.3892\/or.2012.2217","volume":"29","author":"J Li","year":"2013","unstructured":"Li J, Liu H, Li L, Wu H, Wang C, Yan Z, Wang Y, Su C, Jin H, Zhou F, Wu M, Qian Q (2013) The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES\/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma. Oncol Rep 29:895\u2013902","journal-title":"Oncol Rep"},{"key":"9664_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/sj.gt.3302385","volume":"12","author":"B Lu","year":"2005","unstructured":"Lu B, Makhija SK, Nettelbeck DM, Rivera AA, Wang M, Komarova S, Zhou F, Yamamoto M, Haisma HJ, Alvarez RD, Curiel DT, Zhu ZB (2005) Evaluation of tumor-specific promoter activities in melanoma. Gene Ther 12:330\u2013338","journal-title":"Gene Ther"},{"key":"9664_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.virusres.2006.02.001","volume":"119","author":"D Majhen","year":"2006","unstructured":"Majhen D, Ambriovic-Ristov A (2006) Adenoviral vectors--how to use them in cancer gene therapy? Virus Res 119:121\u2013133","journal-title":"Virus Res"},{"key":"9664_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/0092-8674(93)90486-A","volume":"75","author":"M Miura","year":"1993","unstructured":"Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J (1993) Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75:653\u2013660","journal-title":"Cell"},{"key":"9664_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/sj.cgt.7700440","volume":"9","author":"H Mizuguchi","year":"2002","unstructured":"Mizuguchi H, Hayakawa T (2002) Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase. Cancer Gene Ther 9:236\u2013242","journal-title":"Cancer Gene Ther"},{"key":"9664_CR16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/sj.gt.3301453","volume":"8","author":"H Mizuguchi","year":"2001","unstructured":"Mizuguchi H, Koizumi N, Hosono T, Utoguchi N, Watanabe Y, Kay MA, Hayakawa T (2001) A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther 8:730\u2013735","journal-title":"Gene Ther"},{"key":"9664_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0092-8674(00)81874-7","volume":"88","author":"S Nagata","year":"1997","unstructured":"Nagata S (1997) Apoptosis by death factor. Cell 88:355\u2013365","journal-title":"Cell"},{"key":"9664_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/sj.cgt.7700276","volume":"8","author":"Y Nagayama","year":"2001","unstructured":"Nagayama Y, Nishihara E, Namba H, Yokoi H, Hasegawa M, Mizuguchi H, Hayakawa T, Hamada H, Yamashita S, Niwa M (2001) Targeting the replication of adenovirus to p53-defective thyroid carcinoma with a p53-regulated Cre\/loxP system. Cancer Gene Ther 8:36\u201344","journal-title":"Cancer Gene Ther"},{"key":"9664_CR19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/ijc.2910400218","volume":"40","author":"VR Nerurkar","year":"1987","unstructured":"Nerurkar VR, Seshadri R, Mulherkar R, Ishwad CS, Lalitha VS, Naik SN (1987) Receptors for epidermal growth factor and estradiol in canine mammary tumors. Int J Cancer 40:230\u2013232","journal-title":"Int J Cancer"},{"key":"9664_CR20","first-page":"827","volume":"62","author":"H Nishi","year":"2002","unstructured":"Nishi H, Nishi KH, Johnson AC (2002) Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res 62:827\u2013834","journal-title":"Cancer Res"},{"key":"9664_CR21","first-page":"7913","volume":"61","author":"N Okada","year":"2001","unstructured":"Okada N, Saito T, Masunaga Y, Tsukada Y, Nakagawa S, Mizuguchi H, Mori K, Okada Y, Fujita T, Hayakawa T, Mayumi T, Yamamoto A (2001a) Efficient antigen gene transduction using Arg-Gly-asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells. Cancer Res 61:7913\u20137919","journal-title":"Cancer Res"},{"key":"9664_CR22","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1006\/bbrc.2001.4527","volume":"282","author":"N Okada","year":"2001","unstructured":"Okada N, Tsukada Y, Nakagawa S, Mizuguchi H, Mori K, Saito T, Fujita T, Yamamoto A, Hayakawa T, Mayumi T (2001b) Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors. Biochem Biophys Res Commun 282:173\u2013179","journal-title":"Biochem Biophys Res Commun"},{"key":"9664_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0304-3835(01)00768-6","volume":"177","author":"Y Okada","year":"2002","unstructured":"Okada Y, Okada N, Nakagawa S, Mizuguchi H, Kanehira M, Nishino N, Takahashi K, Mizuno N, Hayakawa T, Mayumi T (2002) Fiber-mutant technique can augment gene transduction efficacy and anti-tumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors. Cancer Lett 177:57\u201363","journal-title":"Cancer Lett"},{"key":"9664_CR24","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/sj.cgt.7700824","volume":"12","author":"Y Okada","year":"2005","unstructured":"Okada Y, Okada N, Mizuguchi H, Hayakawa T, Nakagawa S, Mayumi T (2005) Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanoma. Cancer Gene Ther 12:608\u2013616","journal-title":"Cancer Gene Ther"},{"key":"9664_CR25","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","volume":"17","author":"HE Ryan","year":"1998","unstructured":"Ryan HE, Lo J, Johnson RS (1998) HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J 17:3005\u20133015","journal-title":"EMBO J"},{"key":"9664_CR26","first-page":"1398","volume":"1","author":"JR Sainsbury","year":"1987","unstructured":"Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL (1987) Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1:1398\u20131402","journal-title":"Lancet"},{"key":"9664_CR27","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.4049\/jimmunol.180.7.4931","volume":"180","author":"H Sakurai","year":"2008","unstructured":"Sakurai H, Tashiro K, Kawabata K, Yamaguchi T, Sakurai F, Nakagawa S, Mizuguchi H (2008) Adenoviral expression of suppressor of cytokine signaling-1 reduces adenovirus vector-induced innate immune responses. J Immunol 180:4931\u20134938","journal-title":"J Immunol"},{"key":"9664_CR28","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1292\/jvms.66.563","volume":"66","author":"J Sano","year":"2004","unstructured":"Sano J, Oguma K, Kano R, Hasegawa A (2004) Characterization of canine caspase-3. J Vet Med Sci 66:563\u2013567","journal-title":"J Vet Med Sci"},{"key":"9664_CR29","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1158\/1078-0432.CCR-05-1554","volume":"12","author":"M Scaltriti","year":"2006","unstructured":"Scaltriti M, Baselga J (2006) The epidermal growth factor receptor pathway: a model for targeted therapy. Clin Cancer Res 12:5268\u20135272","journal-title":"Clin Cancer Res"},{"key":"9664_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/157488509788185123","volume":"4","author":"A Sharma","year":"2009","unstructured":"Sharma A, Tandon M, Bangari DS, Mittal SK (2009) Adenoviral vector-based strategies for cancer therapy. Current Drug Therapy 4:117\u2013138","journal-title":"Current Drug Therapy"},{"key":"9664_CR31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/gt.2010.1","volume":"17","author":"A Sharma","year":"2010","unstructured":"Sharma A, Tandon M, Ahi YS, Bangari DS, Vemulapalli R, Mittal SK (2010) Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses. Gene Ther 17:634\u2013642","journal-title":"Gene Ther"},{"key":"9664_CR32","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/sj.gt.3301041","volume":"6","author":"K Yamabe","year":"1999","unstructured":"Yamabe K, Shimizu S, Ito T, Yoshioka Y, Nomura M, Narita M, Saito I, Kanegae Y, Matsuda H (1999) Cancer gene therapy using a pro-apoptotic gene, caspase-3. Gene Ther 6:1952\u20131959","journal-title":"Gene Ther"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-016-9664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11259-016-9664-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-016-9664-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:26:34Z","timestamp":1589415994000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11259-016-9664-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,16]]},"references-count":32,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["9664"],"URL":"https:\/\/doi.org\/10.1007\/s11259-016-9664-7","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,16]]},"assertion":[{"value":"29 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors have any conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}